ation. If you are not the intended recipient (or have received this
> e-mail in error) please notify the sender immediately and destroy this
> e-mail. Any unauthorised copying, disclosure or distribution of the
> material in this e-mail is strictly forbidden.
> --
details I expect
> someone else can answer your question (Doug!)
>
>
> cheers
> Bruce
>
>
> On Thu, 13 Oct 2016, Eelco van Duinkerken wrote:
>
> Thanks for the quick reply!
>> So if I understand correctly, the power of say the controls vs. diabetes
>> (indeed it
of whether our implementation is senstitive to
> this. It's that in general your power will be constrained by the size of
> the smaller group (I assume this is Type 2 diabetes by the way).
>
> cheers
> Bruce
>
>
> On Thu, 13 Oct 2016, Eelco van Duinkerken wrote:
>
Hi all,
I am using FS with data from 2 different studies that were acquired on the
same MRI-machine with the same T1 and FLAIR sequences. Unfortunately, the
group sizes are not very balanced, with 31 controls, 16 obese and 32
diabetes patients.
Is the GLM for thickness used in FS very sensitive t
o you
> might check them out. Unfortunately I don't think they will be officially
> supported in 6.0 as we just don't have the resources to include it in our
> unit/system/regression test cycle.
>
> cheers
> Bruce
>
>
> On Tue, 30 Aug 2016, Eelco van Duinkerke
